期刊文献+

外源性组织型纤溶酶原激活物信号肽突变体增强蛋白质在哺乳细胞中的表达及分泌 被引量:3

Improved expression and secretion of protein in mammalian cells by the heterologous tissue plasminogen activator signal peptide mutation
原文传递
导出
摘要 目的 比较不同tPA信号肽突变体对目的蛋白表达和分泌水平的影响,优化并筛选通用性外源信号肽序列.方法 通过定点突变技术将人类组织型纤溶酶原激活物(tPA)的信号肽第22位氨基酸由脯氨酸(P)突变为丙氨酸(tPA22P/A)或甘氨酸(tPA22P/G),并将突变前后的3种信号肽序列分别插入HIV-1 p24基因的N末端,构建不同的p24蛋白表达载体,这些重组表达载体体外瞬时转染人胚肾HEK293T细胞,转染72 h后,通过SDS-PAGE与western blot检测并比较各组培养上清和细胞中p24蛋白的表达水平.结果 成功构建了3个p24蛋白的真核表达载体P24T.tPA、P24T.tPA22P/A和P24T.tPA22P/G,经序列测定证实基因序列和方向与预期相符;重组载体转染293T细胞72 h后均检测到分泌性p24的表达.与P24T.tPA组相比,P24T.tPA22P/A转染组培养上清中和细胞内p24蛋白表达水平分别提高62%和29%,P24T.tPA22P/G转染组分别提高8%和6%.结论 tPA信号肽22位由脯氨酸突变为丙氨酸或甘氨酸,这就提高了目的蛋白的表达和分泌水平,为优化外源蛋白在哺乳细胞中的表达和分泌提供了实验基础. Objective To optimize the tissue plasminogen activator (tPA) signal peptide (tPA-SP) as a universal heterologous signal peptide for the secretory expression of target proteins. Methods Two tPA-SP mutants, tPA22P/A and tPA22P/G, were constructed by substituting the amino acid proline at 22 position of tPA-SP to alanine (A) or glycine (G), respectively. Then, three HIV-1 p24 expression vectors, P24T. tPA,P24T. tPA22P/A and P24T. tPA22P/G were constructed by introducing tPA-SP, tPA22P/A or tPA22P/G into the N terminus of p24 gene. HEK293T cells were transfected by these recombinant vectors. 72h post-transfection, the p24 protein in the supernatant and cell lysate of each transfectant was examined by SDS-PAGE and western blot. Results Three p24 eukaryotic expression vectors P24T. tPA, P24T. tPA22P/A and P24T.tPA22P/G were successfully constructed. The three constructs gave secretory expression of HIV-1 p24 protein.The expression levels of p24 protein driven by P24T. tPA22P/A and P24T. tPA22P/G increased by 62% and 8% in the transferred supernatants, respectively, comparing with that driven by P24T. tPA; and the expressionlevels increased by 29% and 6% in the transferred cell lysates, respectively. Conclusions The amino acid substitution of tPA-SP 22P with alanine or glycine enhanced the expression and secretory levels of the target protein. This work provides an experimental foundation for optimizing the expression and secretion of heterologous proteins in mammalian cells.
出处 《国际免疫学杂志》 CAS 北大核心 2010年第5期403-405,414,共4页 International Journal of Immunology
基金 国家自然科学基金资助项目(30771910) 科技部“十一五”传染病重大专项(2008ZX10001-012) 黑龙江省自然科学基金(ZJY0601-01) 黑龙江省教育厅重点项目(11531206) 黑龙江省研究生创新科研资金(YJSCX2009-222HLJ)
关键词 组织型纤溶酶原激活物 信号肽 哺乳细胞 Tissue plasminogen activator Signal peptide Mammalian cells
  • 相关文献

参考文献2

二级参考文献25

  • 1王克夷.肽链的翻译后加工2.新生肽链穿越粗面内质网系膜[J].生命的化学,1995,15(2):1-4. 被引量:3
  • 2李军,李伯良.蛋白A信号肽引导的E.coli外泌高表达异源蛋白[J].生物化学与生物物理学报,1995,27(6):616-623. 被引量:4
  • 3梅建国,沈志强,贾杏林.猪繁殖障碍与呼吸道综合征病毒基因组及其结构蛋白的研究[J].中国畜牧兽医,2006,33(3):48-50. 被引量:5
  • 4Delputte P L, Vanderheijden N, Nauwynck H J, et al. Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages[J]. J Virol, 2002,76(9) : 4312-4320.
  • 5Fomsgaard A, Nielsen H V, Nielsen C, et al. Comparisons of DNA mediated immunization procedures directed against surface glycolproteins of human immuneodeficiency virus type 1 and hepatitis B virus[J]. APMIS, 1998,106(6) :636-646.
  • 6Gonin P, M ardassi H, Gagnon C A, et al. Anonstructural and antigenic glycoprotein is encoded by ORF3 of the IAF-Klop strain of porcine reproductive and respiratory syndrome virus[J]. Arch Virol, 1998,143(10) : 1927-1940.
  • 7Hall W V. Porcine reproductive and respiratory syndrome (PRRS) virus a significant disease of pigs[J]. August Vet J, 2005,83 (5): 260-261.
  • 8Izard J W, Doughty M B, Kendall D A. Physical and conformational properties of synthetic idealized signal sequences parallel their biological function[J]. Biochemistry, 1995,34(31): 9904.
  • 9Li Z, Howard A, Kelley C, et al. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun, 1999,67 (9) : 4780-4786.
  • 10Lu S,Manning S, Arthos J. Antigen engineering in DNA immu nization. In: Owrie DB, WhalenRG, editors. Methods in molec ular medicine[M]. Totowa, N J: Human Press Inc, 1998, 355-374.

共引文献48

同被引文献48

  • 1Pinter A.Roles of HIV-1 Env variable regions in viral neutralization and vaccine development.Curr HIV Res,2007,5(6):542-553.
  • 2Raska M,Novak J.Involvement of envelope-glycoprotein glycans in HIV-1 biology and infection.Arch Immunol Ther Exp (Warsz),2010,58(3):191-208.
  • 3Schief WR,Ban YE,Stamatatos L.Challenges for structure-based HIV vaccine design.Curr Opin HIV AIDS,2009,4(5):431-440.
  • 4Yang X,Wyatt R,Sodroski J.Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers.J Virol,2001,75(3):1165-1171.
  • 5Wyatt R,Sodroski J.The HIV-1 envelope glycoproteins:fusogens,antigens,and immunogens.Science,1998,280(5371):1884-1888.
  • 6Hoxie JA.Toward an antibody-based HIV-1 vaccine.Annu Rev Med,2010,61:135-152.
  • 7Gilbert PB,Peterson ML,Follmann D,et al.Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.J Infect Dis,2005,191(5):666-677.
  • 8Graham BS,Mascola JR.Lessons from failure-preparing for future HIV-1 vaccine efficacy trials.J Infect Dis,2005,191 (5):647-649.
  • 9Fouts TR,Binley JM,Trkola A,et al.Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomerie form of the envelope glycoprotein complex.J Virol,1997,71(4):2779-2785.
  • 10Kim M,Qiao ZS,Montefiori DC,et al.Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.AIDS Res Hum Retroviruses,2005,21(l):58-67.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部